Nisa Investment Advisors’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.77K Sell
962
-173
-15% -$1.58K ﹤0.01% 2322
2025
Q1
$9.02K Buy
1,135
+405
+55% +$3.22K ﹤0.01% 2125
2024
Q4
$3.96K Sell
730
-10
-1% -$54 ﹤0.01% 2331
2024
Q3
$5.34K Sell
740
-5,490
-88% -$39.6K ﹤0.01% 2213
2024
Q2
$67.7K Sell
6,230
-12,885
-67% -$140K ﹤0.01% 1579
2024
Q1
$358K Buy
19,115
+75
+0.4% +$1.41K ﹤0.01% 1181
2023
Q4
$413K Buy
19,040
+18,490
+3,362% +$401K ﹤0.01% 1108
2023
Q3
$11.3K Sell
550
-1,479
-73% -$30.4K ﹤0.01% 2149
2023
Q2
$95.4K Buy
2,029
+540
+36% +$25.4K ﹤0.01% 1522
2023
Q1
$62K Hold
1,489
﹤0.01% 1644
2022
Q4
$57K Sell
1,489
-140
-9% -$5.36K ﹤0.01% 1731
2022
Q3
$61K Buy
1,629
+90
+6% +$3.37K ﹤0.01% 1671
2022
Q2
$50K Buy
1,539
+1,450
+1,629% +$47.1K ﹤0.01% 1736
2022
Q1
$3K Sell
89
-125
-58% -$4.21K ﹤0.01% 2334
2021
Q4
$8K Sell
214
-121
-36% -$4.52K ﹤0.01% 2056
2021
Q3
$15 Sell
335
-1,702
-84% -$76 ﹤0.01% 2149
2021
Q2
$116 Sell
2,037
-900
-31% -$51 ﹤0.01% 1614
2021
Q1
$220 Hold
2,937
﹤0.01% 1455
2020
Q4
$254K Buy
2,937
+1,912
+187% +$165K ﹤0.01% 1371
2020
Q3
$63K Hold
1,025
﹤0.01% 1713
2020
Q2
$43K Sell
1,025
-3,730
-78% -$156K ﹤0.01% 1612
2020
Q1
$137K Buy
4,755
+750
+19% +$21.6K ﹤0.01% 1284
2019
Q4
$289K Sell
4,005
-12,760
-76% -$921K ﹤0.01% 1240
2019
Q3
$2.35M Buy
16,765
+16,590
+9,480% +$2.33M 0.02% 580
2019
Q2
$32K Hold
175
﹤0.01% 1553
2019
Q1
$28K Sell
175
-1,930
-92% -$309K ﹤0.01% 1584
2018
Q4
$202K Hold
2,105
﹤0.01% 1239
2018
Q3
$297K Buy
2,105
+1,930
+1,103% +$272K ﹤0.01% 1232
2018
Q2
$27K Sell
175
-225
-56% -$34.7K ﹤0.01% 1512
2018
Q1
$64K Sell
400
-50
-11% -$8K ﹤0.01% 1401
2017
Q4
$74K Buy
450
+40
+10% +$6.58K ﹤0.01% 1420
2017
Q3
$26K Hold
410
﹤0.01% 1484
2017
Q2
$33K Hold
410
﹤0.01% 1434
2017
Q1
$29K Buy
410
+10
+3% +$707 ﹤0.01% 1472
2016
Q4
$20K Buy
+400
New +$20K ﹤0.01% 1641